Low SIAH2 expression in breast cancer is associated with resistance to endocrine therapy

被引：0
|
作者：
Jansen, M. P. H. M. [1 ]
Dorssers, L. C. J. [1 ]
Ritstier, K. [1 ]
Foekens, J. A. [1 ]
van Staveren, I. L. [1 ]
Helleman, J. [1 ]
Look, M. P. [1 ]
Sieuwerts, A. M. [1 ]
Klijn, J. G. M. [1 ]
Berns, R. M. J. J. [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)70764-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [41] A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese
    Seham Elgazzar
    Hitoshi Zembutsu
    Atsushi Takahashi
    Michiaki Kubo
    Fuminori Aki
    Koichi Hirata
    Yuichi Takatsuka
    Minoru Okazaki
    Shozo Ohsumi
    Takashi Yamakawa
    Mitsunori Sasa
    Toyomasa Katagiri
    Yoshio Miki
    Yusuke Nakamura
    Journal of Human Genetics, 2012, 57 : 766 - 771
  • [42] Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models
    Kuske, Barbara
    Naughton, Catherine
    Moore, Kate
    MacLeod, Kenneth G.
    Miller, William R.
    Clarke, Robert
    Langdon, Simon P.
    Cameron, David A.
    ENDOCRINE-RELATED CANCER, 2006, 13 (04) : 1121 - 1133
  • [43] Increasing DAXX Expression in ER plus Breast Cancer Cells to Overcome Endocrine Therapy Resistance
    Osipo, Clodia
    Albain, Kathy S.
    Peiffer, Daniel
    Wyatt, Debra
    CANCER RESEARCH, 2023, 83 (05)
  • [44] Siah2 Inhibitor and the Metabolic Antagonist Oxamate Retard Colon Cancer Progression and Downregulate PD1 Expression
    Zakaria, Sherin
    Elsebaey, Samar
    Allam, Shady
    Abdo, Walied
    El-Sisi, Alaa
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024, 19 (01) : 80 - 92
  • [45] Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer
    Ahn, Songyeon
    Park, Jun Hyoung
    Grimm, Sandra L.
    Piyarathna, Danthasinghe Waduge Badrajee
    Samanta, Tagari
    Putluri, Vasanta
    Mezquita, Dereck
    Fuqua, Suzanne A. W.
    Putluri, Nagireddy
    Coarfa, Cristian
    Kaipparettu, Benny Abraham
    CANCER RESEARCH, 2024, 84 (02) : 291 - 304
  • [46] Analysis of factors affecting endocrine therapy resistance in breast cancer
    Zhang, Min
    Chen, Hui
    Gu, Jun
    ONCOLOGY LETTERS, 2016, 11 (01) : 379 - 384
  • [47] Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits?
    Ciara S. O’Brien
    Sacha J. Howell
    Gillian Farnie
    Robert B. Clarke
    Journal of Mammary Gland Biology and Neoplasia, 2009, 14 : 45 - 54
  • [48] Markers of sensitivity, dependence and resistance to endocrine therapy for breast cancer
    Miller, William R.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (03) : 345 - 357
  • [49] Breast Cancer Stem Cells and Their Role in Resistance to Endocrine Therapy
    O'Brien C.S.
    Farnie G.
    Howell S.J.
    Clarke R.B.
    Hormones and Cancer, 2011, 2 (2): : 91 - 103
  • [50] Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer
    Zilli, Marinella
    Grassadonia, Antonino
    Tinari, Nicola
    Di Giacobbe, Alessia
    Gildetti, Simona
    Giampietro, Jamara
    Natoli, Clara
    Iacobelli, Stefano
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2009, 1795 (01): : 62 - 81
12345